Dear Colleagues and Friends, Sponsors and Exhibitors,
The Conference program will be both exciting and
ground-breaking in its wide-ranging and multidisciplinary content. In addition
to traditional abstract presentations and lectures by world renowned invited
speakers, we will be offering workshops, interactive sessions, hands on
workshops as well as several sessions specifically dedicated to nurses,
patients and advocates.
The cross-disciplinary character of the Conference should
fit naturally in the diverse backdrop that is London. Often described as the
most diverse city in the world and was rated the world’s most livable city. We look forward to welcoming you to an inspiring,
educational, and enjoyable program in vibrant, beautiful and multicultural
It is our pleasure and honor to extend to you a warm invitation to attend and participate in the International Webinar on Hematology and Medical Oncology 2020 of the International Association for the study of hematology to be held September 21-22, 2020 in the city of London, UK.
The International Webinar on hematology and medical oncology 2020 has become the premier platform not only for the presentation of new science, but also for unique networking opportunities. Building on the success of previous conferences, the 2020 conference will be world's largest international gathering of clinicians, researchers and scientists in the field of hematology and medical oncology. With delegates from more than 100 countries attending, this conference will provide the ideal forums to discuss the latest findings, we put them into context and really understand how they affect your practice day to day. We encourage physicians, nurses, other clinicians,
researchers and scientists as well as patients and advocates in the hematology
field and those interested in any aspect of medical oncology to attend this
Conference. It is only through an exchange of the widest variety of research that
we can offer the best program and benefits to our members and patients.
The cross-disciplinary of the character of the conference should fit naturally in the diverse backdrop that is London. Often described as the most diverse city in the world and was rated as world's most livable city. We look forward to welcoming you to an inspiring, educational, and enjoyable program in vibrant, beautiful and multicultural London.
International Webinar on Hematology and Medical Oncology will take place on September 21-22, 2020. Hematology 2020 is comprised of many interactive scientificsessions on different types of Blood diseases as well as various diagnostic andtherapeutic advancements in this field. It is an initiative to unite thediverse research and business communities working in this field under aone roof to explore every single aspect of Hematology and Blood Disorders. Hematology 2020 welcomes the immunologists, haematologists,oncologists, pathologists, research scholars, industrial professionals andstudent delegates from biomedical and healthcare sectors to be a part of it in Hematologyconferences. Hematology 2020will include speaker talks, brief keynote presentations, exhibitions andworkshops where researchers and associations will exchange ideas and discussthe methodology for new Diagnostics and treatment methods for HematologicDisorders, care of patients, management and new approaches emerging in Hematology etc.
Webinar share millions ofinformation’s to companies and universities. It is advantageous to researchers and medical students furthermorefor scientific laboratory technicians and professors. Conferences additionallybenefits and share info between scientist, doctors and delegates. One companynetwork with completely different company which they share information to everyalternative regarding their product at the conference. Companies come back toattend conferences and show their exhibit before of eminent members anddelegates present at the Conference. Itwill be amazing opportunity for the participants to explore the beautiful citywith gaining knowledge. To fight against these hard to cure blood disorders, Hematology 2020,has taken this initiative to explore every aspect of Hematologyresearch.
· Student delegates from Academia and Research along with the industrial professionals
· Industrial professionals from biomedical companies and healthcare sectors.
Hematology is the branch of science that focuses on the health and diseases of the blood. Our blood can hold secrets that are not readily visible to the naked eye. When the blood fails to function normally, diseases such as anemia, Clotting disorders, Leukemia, and a number of others can occur. The study of blood and its disorders is called hematology. Scientists or doctors who study the blood are called hematologists, and they specifically look at blood health and blood diseases.
Blood is composed of red blood cells, white blood cells, and platelets. Organs of the body affected by, or used to, transport blood include the blood vessels, bone marrow, lymph nodes, and spleen. Proteins in the body are also involved in bleeding and clotting. Diseases treated by Hematologists are sickle cell anemia or trauma relate anemia. Polycythemia or excess production of red blood cells, myelofibrosis, Leukemia, multiple myeloma, malignant lymphomas, blood transfusion and bone marrow stem cell transplantation.
Blood consists of four components: White blood cells, red blood cells, platelets and plasma- that help oxygenate our organs and tissues, act as a defence against infections and form clots to stop bleeding. But these components may also indicate the presence of abnormalities, which sometimes lead to blood cancers. That is where hematology-medical oncology comes into play
Hematology-Medical Oncology refers to the combined medical practice of hematology (The study of the blood’s physiology) and oncology (The study of cancer). This type of medicine diagnoses and treats cancerous blood disorders and cancers, and manages symptoms of these diseases and resultant tumors.
· Hodgkin lymphoma
· Non-Hodgkin lymphoma
· Iron deficiency anemia
· Sickle cell disease
· Multiple myeloma
· Clotting disorders
· Polycythemia vera
· Von Willebrand disease
Blood transfusion is defined as the process of receiving whole blood or blood products into one’s systemic circulation intravenously. It may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Blood transfusion is usually done during accidents or during surgery, in cases of deficiencies, to increase the oxygen saturation, to treat hematologic conditions such as severe anemia, leukemia, and sickle cell disease. Blood transfusion may also be associated with various complications including infections, immunological disorders such as hemolysis or incompatibilities.
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet.
Major Blood disorders include:
· Platelet Disorders
· White Blood Disorders
After the physical assessment, for the identification of blood issues doctor normally go for a complete blood tally. This is the essential test after that to analyse a blood issue, the specialist generally should do additional blood tests once an advisor finds that something isn’t right with at least one of the blood cells types, numerous extra tests are accessible for additional identification of illness. Doctors can measure proportion of different types of WBCs and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Tests are made to measure the ability of white blood cells to fight foreign body infection, to evaluate the functioning of blood platelets and their ability of WBCs to fight foreign body infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow samples as well for Bone Marrow Examination. Once the problem is diagnosed Hematologists go for the appropriate treatment for the problem.
Blood Disorder 2020 Conferences | Blood Cancer Diagnosis Conferences | Blood Disorder Treatment Meetings | Oncology Conferences | Hematology European Conferences | Hematological Malignances Diagnosis Conferences
Immunohematology is also known as blood banking. It is a branch of Hematology which studies antigen-antibody reactions and the similar phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. The people working in this field are called as immuno-hematologist. Cross-matching, blood typing and antibody identification are their usual duties. This area is dealing with preparing blood components and blood for transfusion and assortment of more compatible components for blood transfusion. People might be immunized to RBCs due to prior contact to RBCs of other persons, frequently through pregnancy or transfusion. Antigens are present on the RBC.
Paediatric hematology deals with general hematological problems seen in neonates or pediatric patients. Haematopoiesis is different in pediatric patients and neonates compared to adults. By birth, virtually all bone marrow cavities are actively hematopoietic. In childhood, hematopoiesis moves to central bones. Blood viscosity, oxygen delivery, Iron and transferring content, red cell antigens and many other features are different in neonates and children compared to adults. Hence a thorough research enabling a proper diagnosis and treatment of all the haematological disorders in neonates and paediatric patients is highly necessary.
Issues dealt under hematology
· Neonatal anaemia
· Anaemia of prematurity
· Dyserythropoietic Anaemia
Hematologic disorders can affect the central and peripheral nervous systems in several alternative ways, producing a range of neurologic disturbances. They result in nervous system disfunction through a variety of mechanisms, including vascular occlusion, hemorrhage, infiltration and metabolic disturbance, which may be hereditary or acquired. Its frequent cause of certain syndromes, such as venous thrombosis, but rarer causes of a wide range of neurologic conditions. Hematologic disease should be considered as a cause of subacute multifocal disorders.
STEM CELL RESEARCH
Stem cell research deals with research and publication of high-quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent.
Various types of known stem cells:
· Embryonic stem cells
· Foetal and Adult stem cells
· Haemopoietic stem cells
· Cancer stem cells
Cardio-Oncology is to find a balance between oncologic efficacy and reducing antagonistic cardiovascular effects over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play a crucial role in the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular hitches of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-onco-hematology which allow its claim in regular clinical preparation so to promote the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.
· Cardio vascular problems
· Immune System
· Medicine Perspectives
Hematology and Cardio-Oncology 2020 Conferences | Blood Cancer Diagnosis Conferences | Blood Disorder Treatment Meetings | Oncology 2020 Conferences | Hematology European Conferences | Hematological Malignances Diagnosis Conferences
Cancer Epidemiology represents the study of factors responsible for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer can facilitate the formulation of suitable therapeutic treatment methods and preventive medicines for cancer. When cancer is diagnosed, staging tests help determine how extensive the cancer is in terms of its location, size, growth into nearby structures, and spread to other parts of the body.
Three types of epidemiologic research apply to the field of cancer. Descriptive epidemiology focuses on the trends and frequency of disease in a given population. Analytic epidemiology deals with identifying causes and the predisposing risk associated with the development of disease. Clinical epidemiology outlines screening programs and evaluates the impact of prevention strategies on overall outcome. Environmental carcinogens are ubiquitous but often avoidable if aware.
· Diagnosis & Staging
· Tests & Staging
· Cancer Prevention & Control
Cancer Epidemology 2020 Conferences | Blood Cancer Diagnosis Conferences | Blood Disorder Treatment Meetings | Oncology Conferences | Hematology European Conferences | Hematological Malignances Diagnosis Conferences
Thalassemia known to be an inherited blood disorder which is capable of forming abnormal haemoglobin synthesis. It is suspected to be a genetic disorder inherited by parents. This of two types Alpha Thalassemia and Beta Thalassemia this cannot synthesis beta globin, as well thalassemia intermedia which is less severe, the severity depends on no of genes that have been missing Symptoms may vary depending upon the type from mild to severe anaemia, this can lead to tired, pale skin, enlargement of spleen, bone deformities, delayed growth and development and sometimes dark urine in children.
· Genetic disorders
Thalassemia 2020 Conferences | Blood Cancer Diagnosis Conferences | Blood Disorder Treatment Meetings | Oncology Conferences | Hematology European Conferences | Hematological Malignances Diagnosis Conferences
Polymerase chain reaction (PCR) is a technique used in molecular biology to amplify a single or a few copies of a segment of DNA across several orders of magnitude, generating many copies of a particular DNA sequence. PCR has rapidly become an invaluable technique for the detection and clinical management of a wide variety of haematological disorders. It provides a rapid method for the generation of large quantities of relatively pure DNA sequences of interest. This facilitates nucleotide sequence analysis in both normal and pathological haemopoietic populations.
Advancements in PCR helps in:
· Detection of Chromosomal Translocations
· Detection of Gene Expression
· Detection of Clonality
· Sequencing of Oncogenes
Hematology and Medical Oncology Conferences | Oncology 2020 Conferences | Oncology Congress | Hematology and Cardio oncology 2020 Conferences | Hematology European Conferences | Hematopoietic Malignances Conferences
Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like BI-010 and IHC markers are developed.
Biomarkers in Hematopathology Conferences | Hematopathology 2020 Conferences | Hematology 2020 Meetings | Hematologic Disorder and Diseases Conferences | Hematology European Conferences | Hematological Malignances Conferences
Hematopathology is the subdivision of pathology which studies disorders of haematopoietic cells. Hematopathology is otherwise known as hemopathology. Hematopathology involves the analysis of the cellular elements of blood, body fluids, bone marrow and lymphoid tissues with a focus on neoplastic and non-neoplastic hematologic disorders. Hematopathology laboratories perform a wide variety of specialized studies such as haemoglobin variant analysis and red cell membrane disorders. Hematopathology is a subspecialty, practiced by those physicians. The hematopathology branch distributes analytical services and specialized testing for patients with all types of hematological disorders.
Hematopathology Conferences 2020 | Hematopathology 2020 Conferences | Hematology 2020 Meetings | Hematologic Disorder and Diseases Conferences 2020 | Hematology European Conferences | Hematological Malignances Conferences
GLOBAL HEMATOLOGY SOCIETIES:
HEMATOLOGY SOCIETIES IN USA
EUROPEAN HEMATOLOGY SOCIETIES
ASIA-PACIFIC HEMATOLOGY SOCIETIES
Latest Updates/News on Medical Research:
Experimental Immunotherapy can put patients with relapsed or refractory lymphoma into remission:
For pancreatic disease a novel drug discovery in biomarkers like BI-010 and IHC markers are developed. Let’s have a brief discussion on this at Hematology 2020 conference. Best platform you have ever experienced.
The hematology diagnostics marketplace was esteemed at US$ 3,167.2 million in 2017 and predictable to scope US$ 5,288.3 million by 2026 at a CAGR of 5.9% throughout the prognostication period from 2018 to 2026. The Global Hematology Analyzer and Reagent market is valued at USD 3654.18 million in 2018 and expected to reach USD 6344.23 million by 2025 with a CAGR of 8.20% over the forecast period. Hemophilia market is expected to witness a CAGR of 5.9% during the forecast period. Each year in the United States about 400 babies are born with haemophilia. According to the World Federation of Hemophilia, 184,723 people were affected with Hemophilia in 2016, along with 39,495 people with other bleeding disorders. About 6,000 people are suffering from hemophilia in the United Kingdom (as in 2018). There are approximately 5400 people in the UK with hemophilia A and about 1100 with hemophilia B. Hence the high prevalence of the diseases is acting as one of the factors fueling the market growth all over the globe.
In 2017 the Globally hematology diagnostics marketplace scope was valued at USD 5.96 billion. The CAGR of 5.85% over the estimate retro is foreseen to extend. Aspects such as cumulative pervasiveness of blood disorders tied with collective consciousness about these ailments, and presence of classy & latest technologies are projected to boost the market progress.
Approximately 1 million novel cases of blood malignancy are anticipated to be spotted by 2020 by conferring to an artefact issued by Bristol-Myers Squibb, that is estimated to reason for only 6.0% of all new-fangled tumours. Besides, a big range of the world inhabitants have diverse hemoglobinopathies. The high incidence of blood ailments, such that thalassemia is expected to kick the demand for hematology testing.
Advanced investigations within the biomedical phase, exclusively in emerging countries, can boost marketplace development in flow cytometry. Combination of radiologists and intensifying attention on the inhibition, and primary diagnosis of ailments will drive the number of medical imaging measures like MRI and CT assessments in hospitals and ASCs across limitless countries. They are predictable to be the chief progress handlers for the worldwide medical imaging components market.
- Medical Students
- Young Researchers
- Physicians / Consultants / General Practitioners
- Directors / Managers
- Business Entrepreneurs
- Presidents & Vice Presidents / Directors / Administrators
- Hematology Pharma Companies
- Hematology Associations / Societies
- Medical Devices Companies
- Blood disorders
- Bleeding disorders
- Hematology Oncology
- Blood clots
- Blood Transplantation
- Pediatric hematology
- New drug development in hematology
- Hematology Research
- Various aspects of hematology
- Advanced technologies on blood-based products